Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - enalapril maleate, quantity: 10 mg; lercanidipine hydrochloride, quantity: 10 mg - tablet, film coated - excipient ingredients: titanium dioxide; purified talc; povidone; lactose monohydrate; hypromellose; magnesium stearate; microcrystalline cellulose; sodium starch glycollate type a; sodium bicarbonate; macrogol 6000 - treatment of hypertension. treatment should not be initiated with these fixed dose combinations. (see dosage and administration).

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sertraline hydrochloride, quantity: 111.92 mg (equivalent: sertraline, qty 100 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; hyprolose; sodium starch glycollate type a; magnesium stearate; calcium hydrogen phosphate dihydrate; titanium dioxide; hypromellose; polysorbate 80; macrogol 400; peg-150 distearate; lauromacrogol 400 - children and adolescents sertraline hydrochloride is indicated for the treatment of children (aged 6 years of age and older) and adolescents with ocd.,adults sertraline hydrochloride is indicated for: the treatment of major depression, obsessive compulsive disorder (ocd) and panic disorder. sertraline hydrochloride is indicated for the treatment of social phobia (social anxiety disorder) and the prevention of its relapse. sertraline hydrochloride is indicated for the treatment of premenstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sertraline hydrochloride, quantity: 55.96 mg (equivalent: sertraline, qty 50 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; hyprolose; sodium starch glycollate type a; magnesium stearate; calcium hydrogen phosphate dihydrate; titanium dioxide; hypromellose; polysorbate 80; macrogol 400; peg-150 distearate; lauromacrogol 400 - children and adolescents sertraline hydrochloride is indicated for the treatment of children (aged 6 years of age and older) and adolescents with ocd.,adults sertraline hydrochloride is indicated for: the treatment of major depression, obsessive compulsive disorder (ocd) and panic disorder. sertraline hydrochloride is indicated for the treatment of social phobia (social anxiety disorder) and the prevention of its relapse. sertraline hydrochloride is indicated for the treatment of premenstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

galen ltd - macrogol '3350'; potassium; chloride; sodium; bicarbonate - powder - 105gram/1litre ; 5.4mmol/1litre ; 53mmol/1litre ; 65mmol/1litre ; 17mmol/1litre

United States - English - NLM (National Library of Medicine)

ingenus pharmaceuticals, llc - desipramine hydrochloride (unii: 1y58do4my1) (desipramine - unii:tg537d343b) - desipramine hydrochloride 10 mg - desipramine hydrochloride tablets, usp is indicated for the treatment of depression. the use of maois intended to treat psychiatric disorders with desipramine hydrochloride or within 14 days of stopping treatment with desipramine hydrochloride is contraindicated because of an increased risk of serotonin syndrome. the use of desipramine hydrochloride within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated (see warnings and dosage and administration). starting desipramine hydrochloride in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (see warnings and dosage and administration). desipramine hydrochloride is contraindicated in the acute recovery period following myocardial infarction. it should not be used in those who have shown prior hypersensitivity to the drug. cross-sensitivity between this and other dibenzazepines is a possibility.

United States - English - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - oxymorphone hydrochloride (unii: 5y2ei94nbc) (oxymorphone - unii:9vxa968e0c) - oxymorphone hydrochloride 20 mg - oxymorphone hydrochloride extended-release tablets are indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. limitations of usage - because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with extended-release opioid formulations, reserve oxymorphone hydrochloride extended-release tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or immediate-release opioids) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. - oxymorphone hydrochloride extended-release tablets are not indicated as an as-needed (prn) analgesic. oxymorphone hydrochloride extended-release tablets are contraindicated in patients with: - significant respiratory depression - acute or severe bronchial asthma or hypercarbia - known or suspe

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - verapamil hydrochloride, quantity: 180 mg - tablet, modified release - excipient ingredients: microcrystalline cellulose; sodium alginate; povidone; magnesium stearate; hypromellose; macrogol 400; macrogol 6000; purified talc; glycol/butylene glycol montanate; titanium dioxide; iron oxide red - cordilox sr (verapamil hydrochloride) is indicated for the management of hypertension and angina pectoris.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - potassium chloride, quantity: 600 mg - tablet, modified release - excipient ingredients: macrogol 6000; ethylcellulose; cocoa powder; stearic acid; magnesium stearate; titanium dioxide; hypromellose; triacetin - treatment of all types of potassium deficiencies, particularly hypochloraemic or hypokalaemic alkalosis associated with prolonged or intensive diuretic therapy, eg. in hypertension, cardiac failure or massive oedema (potassium replacement is particularly important to patients receiving digitalis, as the clinical response to this drug is seriously affected by hypokalaemia), in renal disease associated with increased potassium excretion eg. nephrotic syndrome; vomiting and diarrhoea, ulcerative colitis, steatorrhoea, diabetes insipidus, and uncontrolled diabetes mellitus; ileostomy or colostomy patients, cirrhosis; cushing's syndrome and dietary insufficiency; during prolonged or intensive treatment with corticosteroids, acth or carbenoxolone; hyperaldosteronism in megaloblastic anaemia, during the early stages of treatment. here span-k is indicated if a diet rich in potassium cannot be guaranteed.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - sertraline hydrochloride, quantity: 111.9 mg (equivalent: sertraline, qty 100 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; hyprolose; sodium starch glycollate; calcium hydrogen phosphate; macrogol 8000; hypromellose; macrogol 400; titanium dioxide; polysorbate 80 - children and adolescents: zoloft (sertraline hydrochloride) is indicated for the treatment of children (aged 6 years of age and older) and adolescents with ocd. adults: zoloft (sertraline hydrochloride) is indicated for the treatment of major depression, obsessive compulsive disorder (ocd) and panic disorder. zoloft (sertraline hydrochloride) is indicated for the treatment of social phobia (social anxiety disorder) and the prevention of its relapse. zoloft (sertraline hydrochloride) is indicated for the treatment of premenstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - potassium chloride - not applicable - 1mg/1mg